Background Low-income countries have high morbidity and mortality from drug-resistant
infections, especially from enteric bacteria such as Escherichia coli. In these settings, sanitation …

Background Bacterial pathogens cause substantial diarrhea morbidity and mortality among
children living in endemic settings, yet antimicrobial treatment is only recommended for …

Background Shigella is a major cause of diarrhea in young children worldwide. Multiple
vaccines targeting Shigella are in development, and phase 3 clinical trials are imminent to …

Background Molecular diagnostics on human fecal samples have identified a larger burden
of shigellosis than previously appreciated by culture. Evidence of fold changes in …

Background Malawi is among 7 countries participating in the Enterics for Global Health (EFGH)
Shigella surveillance study, which aims to determine the incidence of medically attended …

Background -- Low-income countries have high morbidity and mortality from drug-resistant
infections, especially from enteric bacteria such as Escherichia coli. In these settings, …

Background Low- and middle-income countries (LMICs) have high morbidity and mortality
from drug-resistant infections, especially from enteric bacteria such as Escherichia coli. LMICs …

There are limited data on the pharmacokinetic and safety profiles of dihydroartemisinin-piperaquine
(DHA-PQ) among human immunodeficiency virus-infected (HIV-positive [HIV + ]) …

There is conflicting evidence of the impact of commonly used antiretroviral therapies (ARTs)
on the pharmacokinetics of lumefantrine and the safety profile of artemether-lumefantrine. …

There are limited data on the pharmacokinetic and safety profiles of artesunate-amodiaquine
in human immnunodeficiency virus-infected (HIV + ) individuals receiving antiretroviral …